Front Oncol：多中心数据分析DNA错配修复状态对胃癌预后影响
FRONT ONCOL
GetPortalImpactFactorByIdResponse(projectId=1, id=a9fc13340, cover=https://img.medsci.cn/images/journal/cover/2021/EOx_202109271315057970.jpg, fullname=Frontiers in Oncology, abbr=FRONT ONCOL, pyear=2011, frequence=Irregular, articleNumbers=14479, citedSelf2015=2.1, acceptanceRate=55.09, submissionToAcceptance=3.32, averageReviewTime=平均3.32月, reviewFee=0.0, pageFee=2949.38, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2234-943X, greenSci=https://www.greensci.net/search?kw=2234-943X, scijournal=https://www.scijournal.org/impact-factor-of-FRONT-ONCOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=70.597, medsciHotlight=175.34, medsciHotlight5year=68.2213, citescore=6.2, hIndex=83, impactFactor=4.7, orgnization=Frontiers Media S.A., orgnizationUrl=https://www.frontiersin.org, country=Switzerland, countryCn=瑞士, isOa=1, isOaString=是, sciScie=null, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.frontiersin.org/journals/oncology, websiteHits=32202, guideForAuthor=https://www.frontiersin.org/submission/SubmissionHome.aspx?domainId=2&fieldId=57&specialtyId=0&entityType=1&entityId=451, guideForAuthorHits=6348, submitWebsite=https://www.frontiersin.org/journals/oncology#author-guidelines, submitWebsiteHits=21973, content=<p style="color: #444444;"><em>Frontiers in Oncology</em> publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies.</p>
<p style="color: #444444;">Field Chief Editor Giuseppe Giaccone at Weill Cornell Medicine, Cornell University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific advancement and impactful discoveries on the field of oncology to researchers, academics, clinicians, and the public worldwide..</p>
<p style="color: #444444;">Frontiers in oncology welcomes contributions in the various domains of cancer research, from basic research to clinical studies. The journal is composed of different specialty sections and authors are kindly requested to consider the specific requirements of the most adequate specialty for their submission.</p>
<p style="color: #444444;">Most notably, manuscripts consisting <em>solely</em> of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) <strong>will not</strong> be accepted in any of the sections of Frontiers in Oncology.</p>, totalCites=68053, brief=FRONT ONCOL杂志医学行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #ff0000;">红</span>, medsciComment=FRONT onCOL 是非常火热的杂志，水平中等偏上的优秀杂志，虽然投稿众多，但是仍然建议您尝试，毕竟质量，速度各方面都不错。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href=https://www.medsci.cn/article/'https://www.medsci.cn/sci/submit.do?id=a9fc13340'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br>
本文地址：http://zleialh.tongchengxian.cn/quote/511.html
通成线 http://zleialh.tongchengxian.cn/ , 查看更多
特别提示：本信息由相关企业自行提供，真实性未证实，仅供参考。请谨慎采用，风险自负。
日期：2024-11-12
移动：http://zleialh.tongchengxian.cn/mobile/quote/511.html